Bone Health & Mineral Metabolism
Comprehensive bone mineral optimization formulations engineered to accelerate trabecular bone mineralization, prevent fracture fragility, and avoid calcium-induced constipation.
Clinical Overview & Pathophysiology
In this therapeutic area, Icon Drugs formulates high-stability compounds meeting pharmacopeial limits for content uniformity, dissolution rates, and organic impurities. Our manufacturing adheres to verified batch repeatability so prescribing clinicians can depend upon predictable bioavailability.
For complete bioequivalence dossiers, stability monographs, or hospital tender supply parameters in Bone Health & Mineral Metabolism, please contact our Medical Affairs or Business Enquiry team.
Indications & Conditions5 Addressed
- Osteoporosis
- Osteomalacia
- Bone Fractures
- Post-Menopausal Bone Fragility
- Gestational Hypocalcemia
Formulations in Bone Health & Mineral Metabolism
Active pharmaceutical formulations manufactured under WHO-GMP compliance
Precal Softgel
“In Progressive Bone Disease — The Premium Calcium”
Calcitriol 0.25 mcg + Calcium Carbonate 500 mg + Zinc 7.5 mg + Vit K2-7 + B12 + Folate
Precal-D
“Convert Fragility into Durability — Renders Toughness to Bones”
Calcium Aspartate + Magnesium Hydroxide + Zinc + Vitamin D3